Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 310-314 , September 2006

Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance

  • Akira Katsuki

      Affiliations

    • Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, Japan
    • ,
  • Mina Suematsu

      Affiliations

    • Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, Japan
    • ,
  • Esteban C. Gabazza

      Affiliations

    • Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Mie University School of Medicine, Japan
    • ,
  • Shuichi Murashima

      Affiliations

    • Department of Radiology, Mie University School of Medicine, Japan
    • ,
  • Kaname Nakatani

      Affiliations

    • Department of Laboratory Medicine, Mie University School of Medicine, Japan
    • ,
  • Kenji Togashi

      Affiliations

    • Department of Health and Physical Education, Mie University School of Education, Mie, Japan
    • ,
  • Yutaka Yano

      Affiliations

    • Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, Japan
    • ,
  • Yukihiko Adachi

      Affiliations

    • Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, Japan
    • ,
  • Yasuhiro Sumida

      Affiliations

    • Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, Japan
    • Corresponding Author InformationCorresponding author at: Department of Internal Medicine, Division of Diabetology and Endocrinology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. Tel.: +81 59 232 1111; fax: +81 59 231 5223.

Received 6 June 2005 ,Revised 10 January 2006 ,Accepted 15 February 2006.

References 

  1. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008–2014
  2. Higdon JV, Frei B. Obesity and oxidative stress, a direct link to CVD?. Arterioscler. Thromb. Vasc. Biol. 2003;23:365–367
  3. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J. Clin. Endocrinol. Metab. 2003;88:4673–4676
  4. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114:1752–1761
  5. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism. 2005;54:194–199
  6. Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N, Lagarde M, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-1 adipocytes. Free Radic. Biol. Med. 2005;38:882–889
  7. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699–713
  8. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: What do we know?. J. Clin. Endocrinol. Metab. 2004;89:2569–2575
  9. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Diab. Care. 2003;26:2341–2344
  10. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Nakatani K, et al. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diab. Care. 2004;27:631–632
  11. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Matsumoto K, et al. Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diab. Care. 2003;26:2964–2965
  12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diab. Care 20 (1997) 1183–1197.
  13. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int. J. Obes. 1983;7:437–445
  14. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2004;24:29–33
  15. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr. Atheroscler. Rep. 2005;7:58–62
  16. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004;68:975–981
  17. Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Importance of adipocytokines in obesity-related diseases. Horm. Res. 2003;60:s56–s59
  18. Krieger-Brauer HI, Kather H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest. 1992;89:1006–1013
  19. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension and atherosclerotic cardiovascular disease. Diab. Care. 1991;14:173–194
  20. Habib MP, Dickerson FD, Mooradian AD. Effect of diabetes, insulin and glucose load on lipid peroxidation in the rat. Metabolism. 1994;43:1442–1445
  21. Sampson MJ, Gopaul N, Davies IR, Hughes DA, Carrier MJ. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diab. Care. 2002;25:537–541
  22. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002;23:599–622
  23. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabates. 2002;51:2005–2011
  24. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998;101:1354–1361
  25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486–2497.
  26. Tkác I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diab. Res. Clin. Pract. 2005;68:s2–s9
  27. Nakanishi N, Takatorige T, Fukuda H, Shirai K, LI W, Okamoto M, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diab. Res. Clin. Pract. 2004;64:59–70

PII: S0168-8227(06)00072-6

doi: 10.1016/j.diabres.2006.02.014

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 310-314 , September 2006

Article Tools

* Image Usage & Resolution